http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021198663-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3189130addfe7f682e5cfaa0a5fe9a7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aefb16f9a2c934dfd5ea7120eb50990
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
filingDate 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe3de0c1fcb56b5021491abbfee2df2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8d3d4abacbe216e119e94d03f826fab
publicationDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021198663-A1
titleOfInvention Nanowires/Microscale Pyramids (NWs/MPs) Complex Structure, Method for manufacturing the Same and Its Applications to Isolation of Circulating tumor cells (CTCs) and Detection of Epstein-Barr virus (EBV) DNA
abstract A nanowires/microscale pyramids (NWs/MPs) substrate complex structure is formed with a plurality of pyramids. Each triangular surface of the pyramid is formed with nanowires to increase the contact area. In one application, anti-epithelial-cell adhesion-molecule (anti-EpCAM) antibodies are modified on the nanowires. The anti-EpCAM antibodies serve to capture circulating tumor cells (CTCs) in blood for determining whether the cancer cells have metastasized to other organs. In another application, the nanowires are modified with silver nanoparticles (AgNPs) which can be combined with other functional groups for testing. The AgNPs on the NWs/MPs substrate causes the NWs/MPs substrate to become a substrate with surface enhanced Raman scattering (SERS). The AgNPs are bound with Epstein-Barr virus (EBV) probe DNA which can be hybridized with EBV target DNAs so as to determine the concentration of the EBV target DNAs in blood. The methods for fabricating the substrate and its applications are also provided.
priorityDate 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880

Total number of triples: 27.